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Apoptosis and NFB activation are simultaneously induced in
renal tubulointerstitium in experimental hypertension.
Background. Oxidative stress is known to induce apoptosis
and activation of pro-inflammatory transcription factor nuclear
factor kappa B (NFB), which are biologic effects that may
play a role in the renal damage associated with arterial hyper-
tension. We investigated if increased apoptosis and NFB acti-
vation were present in experimental models of hypertension.
Methods. Sprague-Dawley rats fed with regular rodent chow
and free access to water were studied. The Ang II group (N 
6) received 435 ng/kg/min of angiotensin II during 2 weeks by
subcutaneous minipumps. The l-NAME group (N 5) received
N-nitro-l-arginine-methyl-ester (l-NAME) in the drinking wa-
ter (70 mg/100 mL) for 3 weeks. The control group consisted of
6 rats. Systolic blood pressure (tail cuff plethysmography), serum
creatinine, and proteinuria were determined weekly. Kidneys
were examined for superoxide-positive cells (histochemistry)
and for apoptosis [terminal deoxynucleotidyl transferase-medi-
ated uridine triphosphate nick-end labeling (TUNEL)-positive
cells], proliferation [proliferating cell nuclear antigen (PCNA)-
positive cells), and activation of NFB (p65 subunit) with the
appropriate antibodies.
Results. As expected, hypertension developed in experimen-
tal groups. Tubulointerstitial superoxide-positive cells were in-
creased 7 times (P  0.001), TUNEL-positive cells were in-
creased 3 to 4 times (P  0.001), PCNA-positive cells were
increased 20 to 30 times (P  0.001), and NFB activation was
increased 4 to 5 times (P  0.001) in the experimental groups.
NFB expression correlated with the number of interstitial
lymphocytes (r 0.667, P 0.01) and macrophages (r 0.835,
P  0.001).
Conclusion. Angiotensin II infusion and l-NAME adminis-
tration induce oxidative stress and increased apoptosis and
activation of the transcription factor NFB. These effects may
participate in the development of progressive renal injury re-
sulting from uncontrolled hypertension
Immunocompetent cells are involved in the mecha-
nisms of progression of renal disease of immune-medi-
ated as well as non-immune renal injury [1]. In most, if
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not all, models of arterial hypertension, there is infiltra-
tion of lymphocytes and macrophages in the renal tubu-
lointerstitium and recent investigations have shown that
reduction of this infiltrate prevents or ameliorates the
blood pressure increment induced by a high-salt diet
[2–5]. A constant feature of these experimental models
has been the demonstration of increased oxidative stress
in the kidney, a condition that results from the combined
effects of renal vasoconstriction and interstitial inflam-
mation [6–9].
The interrelation between oxidative stress and intersti-
tial infiltrate has been emphasized by investigations that
show that antioxidant strategies, which are known to im-
prove hypertension in spontaneously hypertensive rats
[10–12], are associated with a reduction in the infiltration
of lymphocytes and macrophages in tubulointerstitial
areas [13, 16], and furthermore, that the intensity of the
immune infiltration and the degree of the oxidative stress
correlate with the severity of hypertension [16].
The present work focuses on cellular events derived
from the increased oxidative stress in models of experi-
mental hypertension. Increased generation of reactive
oxygen species (ROS) is known to trigger mechanisms of
programmed cell death, as well as inflammatory reactiv-
ity, both of which could have considerable relevance in
the progressive deterioration of renal function that is
associated with uncontrolled hypertension. Therefore,
we examined apoptosis and expression of activated nu-
clear factor kappa B (NFB) in the kidney in the experi-
mental models of hypertension induced by chronic an-
giotensin II infusion and nitric oxide synthase (NOS)
inhibition.
METHODS
We have examined renal tissue from rats with salt-
sensitive hypertension described in previous communica-
tions [2, 3]. Male Sprague-Dawley rats (Instituto Vene-
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Fig. 1. After 2 weeks of angiotensin II (Ang II) infusion (black bar)
and 3 weeks of N-nitro-L-arginine-methyl-ester (L-NAME) administra-
tion (gray bar), the blood pressure is significantly elevated. Values are
mean  SD. ***P  0.001.
zolano de Investigaciones Cientı´ficas, Los Teques, Vene-
zuela) receiving a standard rat feed (Protinal, Valencia,
Venezuela) were used in these studies. The following
experimental groups were studied: (1) Ang II group
(N  6), constituted by rats treated with angiotensin II
(Sigma Chemical Co., St Louis, MO, USA) for 2 weeks,
administered at a rate of 435 ng1 · kg1 · min1 by subcu-
taneous minipumps (Alza Corp., Palo Alto, CA, USA);
(2) N-nitro-l-arginine-methyl-ester (l-NAME group)
(N  5) that received l-NAME in the drinking water
(70 mg/100 mL) for 3 weeks; and (3) the Control group,
which consisted of 6 rats. Systolic blood pressure (SBP)
was determined weekly by tail-cuff plethysmography
(IITC, Life Scientific Instruments, Woodland Hills, CA,
USA). All rats were preconditioned to the procedure
of blood pressure determination. Serum creatinine and
proteinuria were determined weekly. At the end of the
experiments, rats were sacrificed under penthotal anes-
thesia and the kidneys were harvested for microscopic
studies.
Histology and immunohistology
Light microscopy was used to study glomerular and
tubulointerstitial damage using a semiquantitative glo-
merular sclerosis index [17] and a tubulointerstitial dam-
age score previously reported [2–4].
Cellular infiltration was evaluated by indirect immu-
nohistology using monoclonal antibodies. Lymphocytes
were identified with anti-CD5 antibody (clone MRCOX19;
Biosource, Camarillo, CA, USA) and macrophages with
anti-ED1 antibody (Harlan Bioproducts, Indianapolis,
IN, USA). Secondary antibodies were purchased from
Accurate Chemical and Scientific Co. (Westbury, NY,
USA). Results were expressed as positive cells per glo-
Fig. 2. Superoxide-positive cells in tubulointerstitial areas of rats of
angiotensin II (Ang II) group (black bar), N-nitro-L-arginine-methyl-
ester (L-NAME) group (gray bar), and control (open bar). Values are
mean  SD. ***P  0.001.
merular cross section (gcs) and positive cells/mm2 in tu-
bulointerstitial regions.
Superoxide production in renal cells was studied in
cryostat sections by the cytochemical method of Briggs
[18] as previously described [19].
Frozen sections were used to detect apoptosis by the
terminal deoxynucleotidyl transferase (TdT)-mediated
dUTB-biotin nick-end labeling methodology (TUNEL)
with commercial apoptosis detection kits (ApoTag;
ONCOR, Gaithersburg, MD, USA). Proliferating cells
were identified with monoclonal antibody to proliferat-
ing cell nuclear antigen (PCNA) obtained from Zymed
Laboratories (San Francisco, CA, USA) utilizing avidin-
biotin-peroxidase methodology. Specific details from
these methods in our laboratories have been reported
previously [19, 20].
Activated NFB was identified in 4-micron cryostat
sections by immunoperoxidase methodology using anti-
body specific for the 65 kD DNA-binding subunit (Zy-
med Laboratories) as detailed in earlier work [15].
Statistical analysis
Comparisons between groups were done by analysis
of variance (ANOVA) and Tukey-Kramer post tests. Re-
sults are expressed as mean  SD throughout the paper
and two-tailed P  0.05 were considered significant.
RESULTS
Systolic blood pressure increased sharply as a result of
Ang II infusion and l-NAME administration. The blood
pressure levels observed at the end of the experiment are
shown in Figure 1. Serum creatinine and urinary protein
excretion increased slightly during the experiment but
did not exceed 0.7 mg/dL and 10 mg/day, respectively.
Superoxide-positive cells were seldom seen in the glo-
meruli. Figure 2 shows that the accumulation of super-
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Fig. 3. Apoptosis [terminal deoxynucleotidyl transferase-mediated
uridine triphosphate nick-end labeling (TUNEL)-positive cells/mm2])
(open bar) and proliferating cells [proliferating cell nuclear antigen
(PCNA)-positive cells/mm2] (black bar) in tubulointerstitial areas in
control, angiotensin II (Ang II) group, and N-nitro-L-arginine-methyl-
ester (L-NAME) group. ***P  0.001 for all data in the corresponding
group vs. the control group.
Fig. 4. Tubulointerstitial activation of nuclear factor kappa B (NFB),
represented as cells positive for the 65p subunit per mm2 (open bars),
and accumulation of lymphocytes (CD5-positive cells/mm2) (black bars)
and macrophages (ED1-positive cells/mm2) (striped bars) in experi-
mental angiotensin II (Ang II) group, N-nitro-L-arginine-methyl-ester
(L-NAME) group and control group. Values are mean  SD. ***P 
0.001 for all the data in each group vs. control group.
oxide-positive cells in both of the experimental groups
was more than 7 times that found in controls.
Apoptosis (TUNEL-positive cells) and proliferation
(PCNA-positive cells) were essentially absent in glomer-
uli but they were increased in tubulointerstitium 34 times
(Ang II group) and 24 times (l-NAME group) as shown
in Figure 3.
Expression of the 65 subunit of NFB was limited also
to the tubulointerstitial areas and it is similarly increased
in both experimental groups. Figure 4 shows these find-
ings in association with the data showing accumulation
of CD5-positive cells and ED1-positive cells. There were
significant correlations between NKB expression and
the number of interstitial lymphocytes (CD5-positive cells)
Fig. 5. Relationship (r  0.835, P  0.001) between the expression of
p65 nuclear factor kappa B (NFB) and macrophage infiltration (ED1-
positive cells. Control group (open circles); angiotensin II (Ang II)
(black squares); N-nitro-l-arginine-methyl-ester (l-NAME) group
(black circles).
and (r  0.667, P  0.01) macrophages (r  0.835, P 
0.001) (Fig. 5). Representative microphotographs are
shown in Figure 6.
DISCUSSION
The association between oxidative stress and hyper-
tension is well recognized and has been demonstrated in
genetic [21, 22] as well as acquired forms of hypertension
[22–28]. The pro-hypertensive effects of ROS are mainly
due to inactivation of nitric oxide and, thereby, endothe-
lial dysfunction with impaired vasodilation. Since ROS
generation is not increased in norepinephrine-induced
hypertension, the elevation of the blood pressure by itself
does not increase oxidant stress [29]. Several studies have
indicated that at least in the angiotensin II–dependent
and angiotensin II–sensitive forms of hypertension, the
formation of oxygen radicals in the vascular endothelium
is the result of angiotensin II activity and is mediated
by the NAD(P)H oxidase system [29–32].
An additional cause of increased ROS production, at
least in the kidney, is the interstitial inflammatory pro-
cess that is a feature of conditions associated with salt-
sensitive hypertension [6]. Lymphocyte and macrophage
infiltration, as well as evidence of oxidative stress, has
been found, among others, in the angiotensin II infusion
model [2] and the l-NAME model [3]. Furthermore,
recent evidence shows significant correlations between
oxidative stress, immune cell infiltration, and blood pres-
sure in the protein overload model [4], and in spontane-
ously hypertensive rats treated with an antioxidant-rich
diet [16]. In the present work, the tubulointerstitial in-
filtration of lymphocytes and macrophages and the in-
creased number of superoxide-positive cells is also dem-
onstrated.
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Fig. 6. Microphotographs showing apoptosis
[terminal deoxynucleotidyl transferase-mediated
uridine triphosphate nick-end labeling (TUNEL)-
positive cells (A and B ), proliferating cells [pro-
liferating cell nuclear antigen (PCNA)-positive
cells] (C and D ), and activated nuclear factor
kappa B (NFB) (p65-positive cells) (E and F )
in biopsies from the control (A, C, and E) and
experimental group (B, D, and F).
Oxidative stress is a well-known stimuli of both apo-
ptosis [33] and activation of NFB [34], which under-
scores the biological need to interrelate cellular prolif-
eration with programmed cell death. In our experiments
it was demonstrated that NFB, which is a rapid response
transcription factor of proinflammatory genes [35], is ac-
tivated by angiotensin II infusion as well as by l-NAME
administration. In addition, there were significant cor-
relations between the expression of the NFB p65 sub-
unit and the number of interstitial lymphocytes and mac-
rophages (Fig. 5). NFB mediates the synthesis of a
variety of cytokines and, in addition, favors leuko-
cyte transmigration since it mediates an increase in the
expression of E-selectin, Vascular cellular adhesion mole-
cule-1 (VCAM-1) and intercellular adhesion molecule-1
(ICAM-1) [36, 37]. Consistent with the role of NFB
in the pathogenesis of the inflammatory infiltration in
hypertension is the recent demonstration that antioxi-
dant treatments reduce NFB activity, and inflammation
in double transgenic rats for human and angiotensinogen
genes [13] and in DOCA-salt hypertensive rats [14].
Therefore, NFB is likely involved in the pathogenesis
of the interstitial immune infiltration, possibly in associa-
tion with other pathways that promote cell adhesion and
proliferation that are activated by angiotensin II and
l-NAME administration, such as the small GTPase Rho
pathway [38, 39].
The possible effect of NFB on apoptosis in the experi-
mental conditions of this paper is less clear. The best
recognized effect of NFB is anti-apoptotic as a result
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of its ability to suppress activation of caspase-8 [40].
Furthermore, NFB is involved in the mechanism of
platelet-derived growth factor (PDGF) signaling [41],
which is a survival factor. On the other hand, recent
evidence indicates that in certain cell types NFB may
be pro-apoptotic, since its activation may induce FasL
expression [42].
CONCLUSION
The increase in apoptosis and activation of NFB dem-
onstrated in experimental models of hypertension may
be relevant to the mechanisms of salt-sensitivity in hyper-
tension. The loss of peritubular capillaries, which would
impair pressure natriuresis, and the interstitial immune
infiltration are part of the pathogenesis of this condition
[8, 9]. In addition, the interstitial infiltration of immune
cells may play a determinant role in renal disease pro-
gression [1] and, consequently, these events may be rele-
vant to the risk of chronic renal failure associated with
long-term arterial hypertension.
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